Indeed, others have noted that epigenetic regulation of skeletal muscle PGC1α resulting in decreased gene expression leads to a reduction in skeletal muscle mitochondrial number and decreased expression of PGC1α target genes in association with disease state, specifically insulin resistance and T2D [7, 21]. The gene discussed is PPARGC1A; the disease is Insulin resistance.